EX-99.1 2 algm-ex99_1.htm EX-99.1 EX-99.1

Exhibit 99.1

Allegro MicroSystems Reports Fourth Quarter and Fiscal Year 2025 Results

Fourth Quarter Sales Increased 8% Sequentially to $193 Million

Manchester, NH, May 8, 2025 – Allegro MicroSystems, Inc. (“Allegro” or the “Company”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced financial results for its fourth quarter and full fiscal year ended March 28, 2025.

“During the fourth quarter, we delivered on our commitments with sales of $193 million, up 8% sequentially, and non-GAAP EPS of $0.06,” said Mike Doogue, President and CEO of Allegro. “While the environment remains dynamic, we are encouraged by the positive momentum we are seeing across the business and the signals we are seeing from our customers. We are taking actions to accelerate growth in strategic focus areas, secure important customer wins and drive operating efficiencies, while improving profitability. As Allegro’s CEO, I am excited to leverage the breadth and depth of my experience to help accelerate our path toward our target financial model and unlock additional shareholder value.”

Fourth Quarter and Full Fiscal Year 2025 Financial Highlights:

In thousands, except per share data

 

Three-Month Period Ended

 

 

Twelve-Month Period Ended

 

 

March 28, 2025

 

 

December 27, 2024

 

 

March 29, 2024

 

 

March 28, 2025

 

 

March 29, 2024

 

 

 

(Unaudited)

 

 

(Unaudited)

 

 

(Unaudited)

 

 

(Unaudited)

 

 

(Unaudited)

 

Net Sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Automotive

 

$

140,880

 

 

$

130,066

 

 

$

181,939

 

 

$

544,023

 

 

$

759,454

 

Industrial and other

 

 

51,944

 

 

 

47,806

 

 

 

58,642

 

 

 

180,983

 

 

 

289,913

 

Total net sales

 

$

192,824

 

 

$

177,872

 

 

$

240,581

 

 

$

725,006

 

 

$

1,049,367

 

GAAP Financial Measures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin %

 

 

41.4

%

 

 

45.7

%

 

 

51.2

%

 

 

44.3

%

 

 

54.8

%

Operating margin %

 

 

(6.8

)%

 

 

(0.0

)%

 

 

6.6

%

 

 

(2.7

)%

 

 

18.7

%

Diluted EPS

 

$

(0.08

)

 

$

(0.04

)

 

$

(0.04

)

 

$

(0.39

)

 

$

0.78

 

Non-GAAP Financial Measures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin %

 

 

45.6

%

 

 

49.1

%

 

 

53.8

%

 

 

48.0

%

 

 

56.3

%

Operating margin %

 

 

9.0

%

 

 

10.8

%

 

 

23.8

%

 

 

9.5

%

 

 

28.5

%

Diluted EPS

 

$

0.06

 

 

$

0.07

 

 

$

0.25

 

 

$

0.24

 

 

$

1.35

 

Business Outlook

For the first quarter of fiscal year 2026 ending June 27, 2025, the Company expects total net sales to be in the range of $192 million to $202 million. At the mid-point of this range, it implies net sales growth of 18% year-over-year.

The Company also estimates the following results on a non-GAAP basis:

Gross Margin is expected to be between 46% and 48%,
Interest expense of approximately $5 million inclusive of a $25 million voluntary debt payment made on April 30, and
Diluted Earnings per Share are expected to be between $0.06 and $0.10.

 

 

Allegro has not provided a reconciliation of its first fiscal quarter outlook for non-GAAP Gross Margin, non-GAAP Operating Expenses, non-GAAP Interest Expense, and non-GAAP Diluted Earnings per Share because estimates of all of the reconciling items cannot be provided without unreasonable efforts. It is difficult to reasonably provide a forward-looking estimate between such forward-looking non-GAAP measures and the comparable forward-looking U.S. generally accepted accounting principles (“GAAP”) measures. Certain factors that are materially significant to Allegro’s ability to estimate these items are out of its control and/or cannot be reasonably predicted.


Earnings Webcast

A webcast will be held on Thursday, May 8, 2025 at 8:30 a.m., Eastern Time. Michael C. Doogue, President and Chief Executive Officer, and Derek P. D’Antilio, Executive Vice President and Chief Financial Officer, will discuss Allegro’s business and financial results.

The webcast will be available on the Investor Relations section of the Company’s website at investors.allegromicro.com. A recording of the webcast will be posted in the same location shortly after the call concludes and will be available for at least 90 days.

About Allegro MicroSystems

Allegro MicroSystems, Inc. is leveraging more than three decades of expertise in magnetic sensing and power ICs, to propel automotive, clean energy and industrial automation forward with solutions that enhance efficiency, performance and sustainability. Allegro’s commitment to quality drives transformation across industries, reinforcing our status as a pioneer in “automotive grade” technology and a partner in our customers' success. For additional information, please visit https://www.allegromicro.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, contained in this press release including statements regarding our future results of operations and financial position, business strategy, prospective products and the plans and objectives of management for future operations, including, among others, statements regarding the liquidity, growth and profitability strategies and factors affecting our business are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

Without limiting the foregoing, in some cases, you can identify forward-looking statements by terms such as “aim,” “may,” “will,” “should,” “expect,” “exploring,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “would,” “contemplate,” “believe,” “estimate,” “predict,” “potential,” “seek,” or “continue” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. No forward-looking statement is a guarantee of future results, performance or achievements, and one should avoid placing undue reliance on such statements.

Forward-looking statements are based on our management’s current expectations, beliefs and assumptions and on information currently available to us. Such beliefs and assumptions may or may not prove to be correct. Additionally, such forward-looking statements are subject to a number of known and unknown risks, uncertainties and assumptions, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to, those identified in Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended March 29, 2024, as any such factors may be updated from time to time in our Quarterly Reports on Form 10-Q and our other filings with the Securities and Exchange Commission (the “SEC”). These risks and uncertainties include, but are not limited to: downturns or volatility in general economic conditions; our ability to compete effectively, expand our market share and increase our net sales and profitability; our reliance on a limited number of third-party semiconductor wafer fabrication facilities and suppliers of other materials; any failure to adjust purchase commitments and inventory management based on changing market conditions or customer demand; shifts in our product mix, customer mix or channel mix, which could negatively impact our gross margin; the cyclical nature of the semiconductor industry, including the analog segment in which we compete; any downturn or disruption in the automotive market or industry; our ability to successfully integrate the acquisition of other companies or technologies and products into our business; our ability to compensate for decreases in average selling prices of our products and increases in input costs; our ability to manage any sustained yield problems or other delays at our third-party wafer fabrication facilities or in the final assembly and test of our products; our ability to accurately predict our quarterly net sales and operating results and meet the expectations of investors; our dependence on manufacturing operations in the Philippines; our reliance on distributors to generate sales; events beyond our control impacting us, our key suppliers or our manufacturing partners; our ability to develop new product features or new products in a timely and cost-effective manner; any slowdown in the growth of our end markets; the loss of one or more significant customers; our ability to meet customers’ quality requirements; uncertainties related to the design win process and our ability to recover design and development expenses and to generate timely or sufficient net sales or margins; changes in government trade policies, including the imposition of export restrictions and tariffs; our exposures to warranty claims, product liability claims and product recalls; our dependence on international customers and operations; the availability of rebates, tax credits and other financial incentives on end-user demands for certain products; risks, liabilities, costs and obligations related to governmental regulations and other legal obligations, including export/trade control, privacy, data protection, information security, cybersecurity, consumer protection, environmental and occupational health and safety, antitrust, anti-corruption and anti-bribery, product safety, environmental protection, employment matters and tax; the risk of unsolicited acquisition proposals; the volatility of currency exchange rates; our ability to raise capital to support our growth strategy; our indebtedness may limit our flexibility to operate our business; our ability to retain key and highly skilled personnel; the impact of restructuring activities on our business and operating results; our ability to protect our proprietary technology and inventions through patents or trade secrets; our ability to commercialize our products without infringing third-party intellectual property rights; disruptions or breaches of our information technology systems or confidential


information or those of our third-party service providers; any failure to design, implement or maintain effective internal control over financial reporting; changes in tax rates or the adoption of new tax legislation; the negative impacts of sustained inflation on our business; the physical, transition and litigation risks presented by climate change; risks related to ESG matters; and other events beyond our control. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties.

You should read this press release and the documents that we reference completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. All forward-looking statements speak only as of the date of this press release, and except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements, whether as a result of any new information, future events, changed circumstances or otherwise.

This press release includes certain non-GAAP financial measures as defined by the SEC rules. These non-GAAP financial measures are provided in addition to, and not as a substitute for or superior to measures of, financial performance prepared in accordance with GAAP. There are a number of limitations related to the use of these non-GAAP financial measures versus their most directly comparable GAAP equivalents. For example, other companies may calculate non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of the presented non-GAAP financial measures as tools for comparison.

This press release may not be reproduced, forwarded to any person or published, in whole or in part.


ALLEGRO MICROSYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share amounts)

(Unaudited)

 

 

Three-Month Period Ended

 

 

Twelve-Month Period Ended

 

 

March 28, 2025

 

 

March 29, 2024

 

 

March 28, 2025

 

 

March 29, 2024

 

Net sales

 

$

192,824

 

 

$

240,581

 

 

$

725,006

 

 

$

1,049,367

 

Cost of goods sold

 

 

112,945

 

 

 

117,333

 

 

 

403,479

 

 

 

474,838

 

Gross profit

 

 

79,879

 

 

 

123,248

 

 

 

321,527

 

 

 

574,529

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

47,618

 

 

 

45,839

 

 

 

179,649

 

 

 

176,638

 

Selling, general and administrative

 

 

45,459

 

 

 

48,294

 

 

 

161,680

 

 

 

188,429

 

Impairment of long-lived assets

 

 

 

 

 

13,218

 

 

 

 

 

 

13,218

 

Total operating expenses

 

 

93,077

 

 

 

107,351

 

 

 

341,329

 

 

 

378,285

 

Operating (loss) income

 

 

(13,198

)

 

 

15,897

 

 

 

(19,802

)

 

 

196,244

 

Interest and other (expense) income

 

 

(5,240

)

 

 

1,354

 

 

 

(31,142

)

 

 

(1,447

)

Loss on change in fair value of forward repurchase contract

 

 

 

 

 

 

 

 

(34,752

)

 

 

 

(Loss) income before income taxes

 

 

(18,438

)

 

 

17,251

 

 

 

(85,696

)

 

 

194,797

 

Income tax (benefit) provision

 

 

(3,700

)

 

 

24,325

 

 

 

(12,933

)

 

 

41,909

 

Net (loss) income

 

 

(14,738

)

 

 

(7,074

)

 

 

(72,763

)

 

 

152,888

 

Net income attributable to non-controlling interests

 

 

62

 

 

 

41

 

 

 

247

 

 

 

191

 

Net (loss) income attributable to Allegro MicroSystems, Inc.

 

$

(14,800

)

 

$

(7,115

)

 

$

(73,010

)

 

$

152,697

 

Net (loss) income per common share attributable to Allegro MicroSystems, Inc.:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.08

)

 

$

(0.04

)

 

$

(0.39

)

 

$

0.79

 

Diluted

 

$

(0.08

)

 

$

(0.04

)

 

$

(0.39

)

 

$

0.78

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

184,169,928

 

 

 

193,139,519

 

 

 

187,707,391

 

 

 

192,573,169

 

Diluted

 

 

184,169,928

 

 

 

194,487,307

 

 

 

187,707,391

 

 

 

194,674,352

 

 

Supplemental Schedule of Total Net Sales

The following table summarizes total net sales by market within the Company’s unaudited condensed consolidated statements of operations:

 

Three-Month Period Ended

 

 

Change

 

 

Twelve-Month Period Ended

 

 

Change

 

 

March 28, 2025

 

 

March 29, 2024

 

 

Amount

 

 

%

 

 

March 28, 2025

 

 

March 29, 2024

 

 

Amount

 

 

%

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

Automotive

 

$

140,880

 

 

$

181,939

 

 

$

(41,059

)

 

 

(23

)%

 

$

544,023

 

 

$

759,454

 

 

$

(215,431

)

 

 

(28

)%

Industrial and other

 

 

51,944

 

 

 

58,642

 

 

 

(6,698

)

 

 

(11

)%

 

 

180,983

 

 

 

289,913

 

 

 

(108,930

)

 

 

(38

)%

Total net sales

 

$

192,824

 

 

$

240,581

 

 

$

(47,757

)

 

 

(20

)%

 

$

725,006

 

 

$

1,049,367

 

 

$

(324,361

)

 

 

(31

)%

 


ALLEGRO MICROSYSTEMS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

 

 

March 28,

 

 

March 29,

 

 

2025
(Unaudited)

 

 

2024

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

121,334

 

 

$

212,143

 

Restricted cash

 

 

9,773

 

 

 

10,018

 

Trade accounts receivable, net

 

 

84,598

 

 

 

118,508

 

Inventories

 

 

183,914

 

 

 

162,302

 

Prepaid income taxes

 

 

36,662

 

 

 

31,908

 

Prepaid expenses and other current assets

 

 

30,247

 

 

 

33,584

 

Current portion of related party notes receivable

 

 

 

 

 

3,750

 

Assets held for sale

 

 

16,508

 

 

 

 

Total current assets

 

 

483,036

 

 

 

572,213

 

Property, plant and equipment, net

 

 

302,919

 

 

 

321,175

 

Deferred income tax assets

 

 

68,528

 

 

 

54,496

 

Goodwill

 

 

202,475

 

 

 

202,425

 

Intangible assets, net

 

 

262,115

 

 

 

276,854

 

Related party notes receivable, less current portion

 

 

 

 

 

4,688

 

Equity investment in related party

 

 

31,695

 

 

 

26,727

 

Other assets

 

 

70,193

 

 

 

72,025

 

Total assets

 

$

1,420,961

 

 

$

1,530,603

 

Liabilities, Non-Controlling Interests and Stockholders’ Equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Trade accounts payable

 

$

38,733

 

 

$

35,964

 

Amounts due to related party

 

 

6,535

 

 

 

1,626

 

Accrued expenses and other current liabilities

 

 

65,570

 

 

 

76,389

 

Current portion of long-term debt

 

 

1,423

 

 

 

3,929

 

Total current liabilities

 

 

112,261

 

 

 

117,908

 

Long-term debt

 

 

344,703

 

 

 

249,611

 

Other long-term liabilities

 

 

32,897

 

 

 

31,368

 

Total liabilities

 

 

489,861

 

 

 

398,887

 

Commitments and contingencies

 

 

 

 

 

 

Stockholders’ Equity:

 

 

 

 

 

 

Preferred stock

 

 

 

 

 

 

Common stock

 

 

1,843

 

 

 

1,932

 

Additional paid-in capital

 

 

1,012,055

 

 

 

694,332

 

(Accumulated deficit) retained earnings

 

 

(53,591

)

 

 

463,012

 

Accumulated other comprehensive loss

 

 

(30,752

)

 

 

(28,841

)

Equity attributable to Allegro MicroSystems, Inc.

 

 

929,555

 

 

 

1,130,435

 

Non-controlling interests

 

 

1,545

 

 

 

1,281

 

Total stockholders’ equity

 

 

931,100

 

 

 

1,131,716

 

Total liabilities, non-controlling interests and stockholders’ equity

 

$

1,420,961

 

 

$

1,530,603

 

 


ALLEGRO MICROSYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(Unaudited)

 

 

Three-Month Period Ended

 

 

Twelve-Month Period Ended

 

 

March 28, 2025

 

 

March 29, 2024

 

 

March 28, 2025

 

 

March 29, 2024

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income

 

$

(14,738

)

 

$

(7,074

)

 

$

(72,763

)

 

$

152,888

 

Adjustments to reconcile net (loss) income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

15,924

 

 

 

21,834

 

 

 

64,502

 

 

 

71,382

 

Amortization of deferred financing costs

 

 

732

 

 

 

235

 

 

 

2,513

 

 

 

527

 

Deferred income taxes

 

 

(4,755

)

 

 

9,640

 

 

 

(16,301

)

 

 

(18,613

)

Stock-based compensation

 

 

9,617

 

 

 

9,618

 

 

 

41,868

 

 

 

42,457

 

Loss on change in fair value of forward repurchase contract

 

 

 

 

 

 

 

 

34,752

 

 

 

 

Provisions for inventory and expected credit losses

 

 

1,697

 

 

 

435

 

 

 

9,216

 

 

 

10,286

 

Change in fair value of marketable securities

 

 

 

 

 

 

 

 

 

 

 

3,579

 

Impairment of long-lived assets

 

 

 

 

 

13,218

 

 

 

 

 

 

13,218

 

Other non-cash reconciling items

 

 

339

 

 

 

52

 

 

 

6,984

 

 

 

70

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Trade accounts receivable

 

 

(1,275

)

 

 

(5,400

)

 

 

33,081

 

 

 

(7,964

)

Inventories

 

 

7,914

 

 

 

4,061

 

 

 

(30,160

)

 

 

(15,848

)

Prepaid expenses and other assets

 

 

(3,200

)

 

 

(28,181

)

 

 

(4,601

)

 

 

(41,266

)

Trade accounts payable

 

 

(1,423

)

 

 

(3,049

)

 

 

4,044

 

 

 

(12,653

)

Due to and from related parties

 

 

4,551

 

 

 

(1,586

)

 

 

5,115

 

 

 

5,231

 

Accrued expenses and other current and long-term liabilities

 

 

4,970

 

 

 

(1,039

)

 

 

(16,337

)

 

 

(21,579

)

Net cash provided by operating activities

 

 

20,353

 

 

 

12,764

 

 

 

61,913

 

 

 

181,715

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Purchases of property, plant and equipment

 

 

(5,391

)

 

 

(14,272

)

 

 

(39,955

)

 

 

(124,772

)

Purchases of intangible assets

 

 

(1,180

)

 

 

 

 

 

(1,180

)

 

 

 

Acquisition of business, net of cash acquired and working capital adjustment

 

 

 

 

 

 

 

 

319

 

 

 

(408,119

)

Sales of marketable securities

 

 

 

 

 

 

 

 

 

 

 

16,175

 

Net cash used in investing activities

 

 

(6,571

)

 

 

(14,272

)

 

 

(40,816

)

 

 

(516,716

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Net proceeds from Refinanced 2023 Term Loan Facility

 

 

(402

)

 

 

 

 

 

193,081

 

 

 

 

Repayment of 2023 Term Loan Facility

 

 

(30,000

)

 

 

(625

)

 

 

(105,000

)

 

 

(625

)

Borrowings of senior secured debt, net of deferred financing costs

 

 

 

 

 

 

 

 

 

 

 

245,452

 

Repayment of 2020 Term Loan Facility

 

 

 

 

 

 

 

 

 

 

 

(25,000

)

Repayments of other debt

 

 

 

 

 

(99

)

 

 

 

 

 

(842

)

Finance lease payments

 

 

(498

)

 

 

(142

)

 

 

(1,201

)

 

 

(142

)

Receipts on related party notes receivable

 

 

 

 

 

937

 

 

 

1,875

 

 

 

3,750

 

Payments for taxes related to net share settlement of equity awards

 

 

(3,458

)

 

 

(1,077

)

 

 

(16,238

)

 

 

(25,900

)

Proceeds from issuance of common stock under employee stock purchase plan

 

 

1,524

 

 

 

1,736

 

 

 

3,511

 

 

 

3,635

 

Repurchases of common stock

 

 

 

 

 

 

 

 

(853,921

)

 

 

 

Net proceeds from issuance of common stock

 

 

 

 

 

 

 

 

665,850

 

 

 

 

Dividends paid to non-controlling interest

 

 

(19

)

 

 

 

 

 

(19

)

 

 

 

Payment of debt issuance costs

 

 

 

 

 

 

 

 

 

 

 

(1,450

)

Net cash (used in) provided by financing activities

 

 

(32,853

)

 

 

730

 

 

 

(112,062

)

 

 

198,878

 

Effect of exchange rate changes on cash and cash equivalents and restricted cash

 

 

1,216

 

 

 

(796

)

 

 

(89

)

 

 

(421

)

Net decrease in cash and cash equivalents and restricted cash

 

 

(17,855

)

 

 

(1,574

)

 

 

(91,054

)

 

 

(136,544

)

Cash and cash equivalents and restricted cash at beginning of period

 

 

148,962

 

 

 

223,735

 

 

 

222,161

 

 

 

358,705

 

Cash and cash equivalents and restricted cash at end of period:

 

$

131,107

 

 

$

222,161

 

 

$

131,107

 

 

$

222,161

 

 


Non-GAAP Financial Measures

In addition to the measures presented in our condensed consolidated financial statements, we regularly review other measures, defined as non-GAAP financial measures by the SEC, to evaluate our business, measure our performance, identify trends, prepare financial forecasts and make strategic decisions. The key measures we consider are non-GAAP Gross Profit, non-GAAP Gross Margin, non-GAAP Operating Expenses, non-GAAP Operating Income, non-GAAP Operating Margin, EBITDA, Adjusted EBITDA, Adjusted EBITDA margin, non-GAAP Profit before Tax, non-GAAP Income Tax Provision, non-GAAP Effective Tax Rate, non-GAAP Net Income Attributable to Allegro MicroSystems, Inc, non-GAAP Basic and Diluted Earnings per Share, non-GAAP Free Cash Flow, and non-GAAP Free Cash Flow as percentage of net sales (collectively, the “Non-GAAP Financial Measures”). These Non-GAAP Financial Measures provide supplemental information regarding our operating performance on a non-GAAP basis that excludes certain gains, losses and charges of a non-cash nature or that occur relatively infrequently and/or that management considers to be unrelated to our core operations, and in the case of non-GAAP Income Tax Provision, management believes that this non-GAAP measure of income taxes provides it with the ability to evaluate the non-GAAP Income Tax Provision across different reporting periods on a consistent basis, independent of special items and discrete items, which may vary in size and frequency. These Non-GAAP Financial Measures are used by both management and our board of directors, together with the comparable GAAP information, in evaluating our current performance and planning our future business activities.

The Non-GAAP Financial Measures are supplemental measures of our performance that are neither required by, nor presented in accordance with, GAAP. These Non-GAAP Financial Measures should not be considered as substitutes for GAAP financial measures, such as gross profit, gross margin, net income or any other performance measures derived in accordance with GAAP. Also, in the future we may incur expenses or charges, such as those being adjusted in the calculation of these Non-GAAP Financial Measures. Our presentation of these Non-GAAP Financial Measures should not be construed as an inference that future results will be unaffected by unusual or nonrecurring items. These Non-GAAP Financial Measures exclude costs related to acquisition and related integration expenses, amortization of acquired intangible assets, stock-based compensation, restructuring actions, related-party activities and other non-operational costs.

Non-GAAP Income Tax Provision

In calculating non-GAAP Income Tax Provision, we have added back the following to GAAP Income Tax Provision:

Tax effect of adjustments to GAAP results—Represents the estimated income tax effect of the adjustments to non-GAAP Profit before Tax described below and elimination of discrete tax adjustments.

 

Reconciliation of Non-GAAP Gross Profit and Non-GAAP Gross Margin

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Twelve-Month Period Ended

 

 

March 28, 2025

 

 

December 27, 2024

 

 

March 29, 2024

 

 

March 28, 2025

 

 

March 29, 2024

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP Gross Profit

 

$

79,879

 

 

$

81,215

 

 

$

123,248

 

 

$

321,527

 

 

$

574,529

 

GAAP Gross Margin (% of net sales)

 

 

41.4

%

 

 

45.7

%

 

 

51.2

%

 

 

44.3

%

 

 

54.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

 

 

 

5

 

 

 

566

 

 

 

14

 

 

 

1,089

 

Purchased intangible amortization

 

 

4,957

 

 

 

4,875

 

 

 

4,959

 

 

 

19,582

 

 

 

9,282

 

Restructuring costs

 

 

2,350

 

 

 

522

 

 

 

1

 

 

 

4,088

 

 

 

167

 

Stock-based compensation

 

 

697

 

 

 

802

 

 

 

734

 

 

 

2,877

 

 

 

5,359

 

Total Non-GAAP Adjustments

 

$

8,004

 

 

$

6,204

 

 

$

6,260

 

 

$

26,561

 

 

$

15,897

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Gross Profit

 

$

87,883

 

 

$

87,419

 

 

$

129,508

 

 

$

348,088

 

 

$

590,426

 

Non-GAAP Gross Margin (% of net sales)

 

 

45.6

%

 

 

49.1

%

 

 

53.8

%

 

 

48.0

%

 

 

56.3

%

 


 

Reconciliation of Non-GAAP Operating Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Twelve-Month Period Ended

 

 

March 28, 2025

 

 

December 27, 2024

 

 

March 29, 2024

 

 

March 28, 2025

 

 

March 29, 2024

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP Operating Expenses

 

$

93,077

 

 

$

81,256

 

 

$

107,351

 

 

$

341,329

 

 

$

378,285

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and Development Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Research and Development Expenses

 

 

47,618

 

 

 

43,317

 

 

 

45,839

 

 

 

179,649

 

 

 

176,638

 

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

3

 

 

 

333

 

 

 

929

 

 

 

1,571

 

 

 

1,281

 

Restructuring costs

 

 

4,429

 

 

 

568

 

 

 

621

 

 

 

5,426

 

 

 

1,529

 

Stock-based compensation

 

 

3,406

 

 

 

3,960

 

 

 

3,554

 

 

 

14,624

 

 

 

13,894

 

Other costs(1)

 

 

 

 

 

 

 

 

 

 

 

3

 

 

 

 

Non-GAAP Research and Development Expenses

 

 

39,780

 

 

 

38,456

 

 

 

40,735

 

 

 

158,025

 

 

 

159,934

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, General and Administrative Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Selling, General and Administrative Expenses

 

 

45,459

 

 

 

37,939

 

 

 

48,294

 

 

 

161,680

 

 

 

188,429

 

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

116

 

 

 

148

 

 

 

5,649

 

 

 

1,353

 

 

 

20,068

 

Purchased intangible amortization

 

 

535

 

 

 

535

 

 

 

542

 

 

 

2,140

 

 

 

1,752

 

Restructuring costs

 

 

1,656

 

 

 

1,264

 

 

 

1,819

 

 

 

6,011

 

 

 

7,614

 

Stock-based compensation

 

 

5,513

 

 

 

5,826

 

 

 

5,330

 

 

 

24,366

 

 

 

23,204

 

Other costs(1)

 

 

6,921

 

 

 

391

 

 

 

3,514

 

 

 

6,303

 

 

 

3,897

 

Non-GAAP Selling, General and Administrative Expenses

 

 

30,718

 

 

 

29,775

 

 

 

31,440

 

 

 

121,507

 

 

 

131,894

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Impairment of long-lived assets

 

 

 

 

 

 

 

 

13,218

 

 

 

 

 

 

13,218

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Non-GAAP Adjustments

 

 

22,579

 

 

 

13,025

 

 

 

35,176

 

 

 

61,797

 

 

 

86,457

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Operating Expenses

 

$

70,498

 

 

$

68,231

 

 

$

72,175

 

 

$

279,532

 

 

$

291,828

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure, such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions.

 

 

 

Reconciliation of Non-GAAP Operating Income and Non-GAAP Operating Margin

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Twelve-Month Period Ended

 

 

March 28, 2025

 

 

December 27, 2024

 

 

March 29, 2024

 

 

March 28, 2025

 

 

March 29, 2024

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP Operating (Loss) Income

 

$

(13,198

)

 

$

(41

)

 

$

15,897

 

 

$

(19,802

)

 

$

196,244

 

GAAP Operating Margin (% of net sales)

 

 

(6.8

)%

 

 

%

 

 

6.6

%

 

 

(2.7

)%

 

 

18.7

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

119

 

 

 

486

 

 

 

7,144

 

 

 

2,938

 

 

 

22,438

 

Impairment of long-lived assets

 

 

 

 

 

 

 

 

13,218

 

 

 

 

 

 

13,218

 

Purchased intangible amortization

 

 

5,492

 

 

 

5,410

 

 

 

5,501

 

 

 

21,722

 

 

 

11,034

 

Restructuring costs

 

 

8,435

 

 

 

2,354

 

 

 

2,441

 

 

 

15,525

 

 

 

9,310

 

Stock-based compensation

 

 

9,616

 

 

 

10,588

 

 

 

9,618

 

 

 

41,867

 

 

 

42,457

 

Other costs(1)

 

 

6,921

 

 

 

391

 

 

 

3,514

 

 

 

6,306

 

 

 

3,897

 

Total Non-GAAP Adjustments

 

$

30,583

 

 

$

19,229

 

 

$

41,436

 

 

$

88,358

 

 

$

102,354

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Operating Income

 

$

17,385

 

 

$

19,188

 

 

$

57,333

 

 

$

68,556

 

 

$

298,598

 

Non-GAAP Operating Margin (% of net sales)

 

 

9.0

%

 

 

10.8

%

 

 

23.8

%

 

 

9.5

%

 

 

28.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions.

 

 


Reconciliation of EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Twelve-Month Period Ended

 

 

March 28, 2025

 

 

December 27, 2024

 

 

March 29, 2024

 

 

March 28, 2025

 

 

March 29, 2024

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP Net (Loss) Income

 

$

(14,738

)

 

$

(6,799

)

 

$

(7,074

)

 

$

(72,763

)

 

$

152,888

 

GAAP Net (Loss) Income Margin (% of net sales)

 

 

(7.6

)%

 

 

(3.8

)%

 

 

(2.9

)%

 

 

(10.0

)%

 

 

14.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

6,874

 

 

 

7,762

 

 

 

5,382

 

 

 

30,366

 

 

 

10,763

 

Interest income

 

 

(222

)

 

 

(388

)

 

 

(594

)

 

 

(1,524

)

 

 

(3,144

)

Income tax (benefit) provision

 

 

(3,700

)

 

 

(803

)

 

 

24,325

 

 

 

(12,933

)

 

 

41,909

 

Depreciation & amortization

 

 

15,924

 

 

 

16,123

 

 

 

21,737

 

 

 

64,502

 

 

 

71,382

 

EBITDA

 

$

4,138

 

 

$

15,895

 

 

$

43,776

 

 

$

7,648

 

 

$

273,798

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

119

 

 

 

486

 

 

 

7,144

 

 

 

5,742

 

 

 

22,438

 

Impairment of long-lived assets

 

 

 

 

 

 

 

 

13,218

 

 

 

 

 

 

13,218

 

Restructuring costs

 

 

8,277

 

 

 

2,354

 

 

 

2,441

 

 

 

15,112

 

 

 

9,310

 

Stock-based compensation

 

 

9,616

 

 

 

10,588

 

 

 

9,618

 

 

 

41,867

 

 

 

42,457

 

Loss on change in fair value of forward repurchase contract

 

 

 

 

 

 

 

 

 

 

 

34,752

 

 

 

 

Other costs(1)

 

 

6,301

 

 

 

998

 

 

 

(2,319

)

 

 

7,911

 

 

 

3,020

 

Adjusted EBITDA

 

$

28,451

 

 

$

30,321

 

 

$

73,878

 

 

$

113,032

 

 

$

364,241

 

Adjusted EBITDA Margin (% of net sales)

 

 

14.8

%

 

 

17.0

%

 

 

30.7

%

 

 

15.6

%

 

 

34.7

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions and income (loss) in earnings of equity investments.

 

 

 

Reconciliation of Non-GAAP Profit before Tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Twelve-Month Period Ended

 

 

March 28, 2025

 

 

December 27, 2024

 

 

March 29, 2024

 

 

March 28, 2025

 

 

March 29, 2024

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP (Loss) Income before Income Taxes

 

$

(18,438

)

 

$

(7,602

)

 

$

17,251

 

 

$

(85,696

)

 

$

194,797

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

119

 

 

 

486

 

 

 

7,144

 

 

 

5,742

 

 

 

22,438

 

Transaction-related interest

 

 

272

 

 

 

192

 

 

 

163

 

 

 

1,314

 

 

 

325

 

Impairment of long-lived assets

 

 

 

 

 

 

 

 

13,218

 

 

 

 

 

 

13,218

 

Purchased intangible amortization

 

 

5,492

 

 

 

5,410

 

 

 

5,501

 

 

 

21,722

 

 

 

11,034

 

Restructuring costs

 

 

8,482

 

 

 

2,354

 

 

 

2,441

 

 

 

15,317

 

 

 

9,310

 

Stock-based compensation

 

 

9,616

 

 

 

10,588

 

 

 

9,618

 

 

 

41,867

 

 

 

42,457

 

Loss on change in fair value of forward repurchase contract

 

 

 

 

 

 

 

 

 

 

 

34,752

 

 

 

 

Other costs(1)

 

 

6,689

 

 

 

1,427

 

 

 

(2,319

)

 

 

12,351

 

 

 

3,020

 

Total Non-GAAP Adjustments

 

$

30,670

 

 

$

20,457

 

 

$

35,766

 

 

$

133,065

 

 

$

101,802

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Profit before Tax

 

$

12,232

 

 

$

12,855

 

 

$

53,017

 

 

$

47,369

 

 

$

296,599

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions and income (loss) in earnings of equity investments.

 

 

 


Reconciliation of Non-GAAP Income Tax Provision and Non-GAAP Effective Tax Rate

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Twelve-Month Period Ended

 

 

March 28, 2025

 

 

December 27, 2024

 

 

March 29, 2024

 

 

March 28, 2025

 

 

March 29, 2024

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP Income Tax (Benefit) Provision

 

$

(3,700

)

 

$

(803

)

 

$

24,325

 

 

$

(12,933

)

 

$

41,909

 

GAAP effective tax rate

 

 

20.1

%

 

 

10.6

%

 

 

141.0

%

 

 

15.1

%

 

 

21.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tax effect of adjustments to GAAP results

 

 

4,126

 

 

 

398

 

 

 

(19,263

)

 

 

14,200

 

 

 

(9,135

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Income Tax (Benefit) Provision

 

$

426

 

 

$

(405

)

 

$

5,062

 

 

$

1,267

 

 

$

32,774

 

Non-GAAP effective tax rate

 

 

3.5

%

 

 

(3.2

)%

 

 

9.5

%

 

 

2.7

%

 

 

11.0

%

 

 

Reconciliation of Non-GAAP Net Income Attributable to Allegro MicroSystems, Inc. and Non-GAAP Earnings per Share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Twelve-Month Period Ended

 

 

March 28, 2025

 

 

December 27, 2024

 

 

March 29, 2024

 

 

March 28, 2025

 

 

March 29, 2024

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP Net (Loss) Income Attributable to Allegro MicroSystems, Inc.(1)

 

$

(14,800

)

 

$

(6,860

)

 

$

(7,115

)

 

$

(73,010

)

 

$

152,697

 

GAAP Basic weighted average common shares

 

 

184,169,928

 

 

 

184,011,189

 

 

 

193,139,519

 

 

 

187,707,391

 

 

 

192,573,169

 

GAAP Diluted weighted average common shares

 

 

184,169,928

 

 

 

184,011,189

 

 

 

194,487,307

 

 

 

187,707,391

 

 

 

194,674,352

 

GAAP Basic (Loss) Earnings per Share

 

$

(0.08

)

 

$

(0.04

)

 

$

(0.04

)

 

$

(0.39

)

 

$

0.79

 

GAAP Diluted (Loss) Earnings per Share

 

$

(0.08

)

 

$

(0.04

)

 

$

(0.04

)

 

$

(0.39

)

 

$

0.78

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

119

 

 

 

486

 

 

 

7,144

 

 

 

5,742

 

 

 

22,438

 

Transaction-related interest

 

 

272

 

 

 

192

 

 

 

163

 

 

 

1,314

 

 

 

325

 

Impairment of long-lived assets

 

 

 

 

 

 

 

 

13,218

 

 

 

 

 

 

13,218

 

Purchased intangible amortization

 

 

5,492

 

 

 

5,410

 

 

 

5,501

 

 

 

21,722

 

 

 

11,034

 

Restructuring costs

 

 

8,482

 

 

 

2,354

 

 

 

2,441

 

 

 

15,317

 

 

 

9,310

 

Stock-based compensation

 

 

9,616

 

 

 

10,588

 

 

 

9,618

 

 

 

41,867

 

 

 

42,457

 

Loss on change in fair value of forward repurchase contract

 

 

 

 

 

 

 

 

 

 

 

34,752

 

 

 

 

Other costs(2)

 

 

6,689

 

 

 

1,427

 

 

 

(2,319

)

 

 

12,351

 

 

 

3,020

 

Total Non-GAAP Adjustments

 

 

30,670

 

 

 

20,457

 

 

 

35,766

 

 

 

133,065

 

 

 

101,802

 

Tax effect of adjustments to GAAP results(3)

 

 

(4,126

)

 

 

(398

)

 

 

19,263

 

 

 

(14,200

)

 

 

9,135

 

Non-GAAP Net Income Attributable to Allegro MicroSystems, Inc.

 

$

11,744

 

 

$

13,199

 

 

$

47,914

 

 

$

45,855

 

 

$

263,634

 

Basic weighted average common shares

 

 

184,169,928

 

 

 

184,011,189

 

 

 

193,139,519

 

 

 

187,707,391

 

 

 

192,573,169

 

Diluted weighted average common shares

 

 

185,247,919

 

 

 

184,485,792

 

 

 

194,487,307

 

 

 

188,629,402

 

 

 

194,674,352

 

Non-GAAP Basic Earnings per Share

 

$

0.06

 

 

$

0.07

 

 

$

0.25

 

 

$

0.24

 

 

$

1.37

 

Non-GAAP Diluted Earnings per Share

 

$

0.06

 

 

$

0.07

 

 

$

0.25

 

 

$

0.24

 

 

$

1.35

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) GAAP Net (Loss) Income Attributable to Allegro MicroSystems, Inc. represents GAAP Net (Loss) Income adjusted for Net Income Attributable to non-controlling interests.

 

(2) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure, such as project evaluation costs, which consists of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions, income (loss) in earnings of equity investments, and unrealized losses (gains) on investments.

 

(3) To calculate the tax effect of adjustments to GAAP results, the Company considers each Non-GAAP adjustment by tax jurisdiction and reverses all discrete items to calculate an annual non-GAAP effective tax rate (“NG ETR”). This NG ETR is then applied to Non-GAAP Profit Before Tax to arrive at the tax effect of adjustments to GAAP results.

 

 


 

Reconciliation of Non-GAAP Free Cash Flow and Non-GAAP Free Cash Flow as Percentage of Net Sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Twelve-Month Period Ended

 

 

March 28, 2025

 

 

December 27, 2024

 

 

March 29, 2024

 

 

March 28, 2025

 

 

March 29, 2024

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP Operating Cash Flow

 

$

20,353

 

 

$

(8,183

)

 

$

12,764

 

 

$

61,913

 

 

$

181,715

 

GAAP Operating Cash Flow (% of net sales)

 

 

10.6

%

 

 

-4.6

%

 

 

5.3

%

 

 

8.5

%

 

 

17.3

%

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchases of property, plant and equipment

 

 

(5,391

)

 

 

(13,615

)

 

 

(14,272

)

 

 

(39,955

)

 

 

(124,772

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Free Cash Flow

 

$

14,962

 

 

$

(21,798

)

 

$

(1,508

)

 

$

21,958

 

 

$

56,943

 

Non-GAAP Free Cash Flow (% of net sales)

 

 

7.8

%

 

 

(12.3

)%

 

 

(0.6

)%

 

 

3.0

%

 

 

5.4

%

Investor Contact:

Jalene Hoover

VP of Investor Relations & Corporate Communications

+1 (512) 751-6526

[email protected]